Company intelligence / Profile preview
Poli Pharmaceutics
Owens Cross Roads, AL, USApolypharm.net ↗
- Ownership
- Private
- Employees
- ~39
- Development stage
- Other
01
Overview
Poly Pharmaceuticals develops, manufactures, markets, and distributes a range of branded, generic, and OTC pharmaceutical products focused on cough/cold, allergy/sinusitis, pain relief, and urological health. The company was acquired by ADDvise Group AB in October 2021. It continues to operate as an active specialty pharma business with commercialized products such as Alahist, Deconex, Duraflu, Poly Hist/Poly Tussin/Poly Vent/Udamin SP.
- Therapeutic areas
- Men's HealthNeurologyInfectious DiseasesImmunology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
AxisCare Health Logistics Inc. (distribution order)
Beyond the preview
Go deeper on Poli Pharmaceutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Poli Pharmaceutics.